Boston Scientific launches new catheter for angioplasty

Boston Scientific has announced the launch of its new Coyote Balloon Catheter, which is designed for use in peripheral angioplasty procedures below the knee.

The product is a highly deliverable and ultra-low profile 0.014-inch balloon dilatation catheter that offers a low lesion entry profile, an excellent crossing profile and high deliverability performance, thanks to its optimised shaft.

Other benefits of the device include its rapid deflation times and wide range of available configurations, with marketing for the Coyote catheter having commenced in Europe, the US and other territories this week.

Jeff Mirviss, president of Boston Scientific's peripheral interventions division, said: "With an ultra-low profile and extended balloon lengths on a variety of catheter platforms, the Coyote Balloon Catheter is designed specifically for interventionalists treating patients with demanding peripheral lesions below the knee."

Last week, the company announced that Michael Mahoney is to become its new president and chief executive officer, following the completion of a transition period.